RECOVERY Respiratory Support (RS)
Ventilation strategies in COVID-19 – CPAP, high-flow, and standard care
Site and lead:
- MFT: Dr Andrew Bentley
Patient group: All COVID-19 patients
Funder: NIHR Central Commissioning Facility (CCF)
Sponsor: University of Warwick
More about RECOVERY RS
- RECOVERY is a nationally-prioritised COVID-19 study. See the full list Urgent Public Health COVID-19 Studies on the NIHR website.
- Read more about RECOVERY at MFT in our website news story.
The purpose of this trial is to test if existing or new drugs can help patients hospitalised with confirmed COVID-19.
The therapies being tested will be evaluated to see if they are safe and effective when added to the usual standard of care.
RECOVERY has an ‘adaptive’ design, meaning it can test new therapies as they become available. The aim is for national data to be available to inform patient treatment within three months.